Xenical/Orlistat Capsules
Company: RocheApproval Status: Approved April 1999
Treatment for: Endocrinology
Areas: Diabetes / Endocrinology
General Information
Xenical/Orlistat Capsules, 120 mg, a lipase inhibitor, have been approved for obesity management. Xenical acts by inhibiting the absorption of dietary fats.
Xenical/Orlistat Capsules Drug Information
The Xenical/orlistat Capsules drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
